RBC Shifts Sector Focus to Health Care, Downgrades Materials and Select Stocks

By EC Assets · Published 14 October 2026

RBC Capital Markets has adjusted its sector allocations, shifting its focus from technology to health care. The firm also downgraded its outlook on the materials sector. These strategic changes reflect evolving perspectives on different market segments. RBC Capital Markets specifically downgraded Amrize (AMRZ) to underperform from sector perform. This downgrade was issued because strong volume growth for the company did not translate into expected profit and margin performance. The shares of Biohaven also experienced a decline following a downgrade from RBC. RBC reduced its price target for the stock as well. This article is intended for informational purposes only. It does not constitute investment advice.